1. Home
  2. ANY vs SABS Comparison

ANY vs SABS Comparison

Compare ANY & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANY
  • SABS
  • Stock Information
  • Founded
  • ANY N/A
  • SABS 2014
  • Country
  • ANY United States
  • SABS United States
  • Employees
  • ANY N/A
  • SABS N/A
  • Industry
  • ANY Finance: Consumer Services
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANY Finance
  • SABS Health Care
  • Exchange
  • ANY Nasdaq
  • SABS Nasdaq
  • Market Cap
  • ANY 16.4M
  • SABS 15.8M
  • IPO Year
  • ANY N/A
  • SABS N/A
  • Fundamental
  • Price
  • ANY $0.70
  • SABS $2.82
  • Analyst Decision
  • ANY Strong Buy
  • SABS Strong Buy
  • Analyst Count
  • ANY 1
  • SABS 4
  • Target Price
  • ANY $3.00
  • SABS $9.50
  • AVG Volume (30 Days)
  • ANY 552.0K
  • SABS 103.0K
  • Earning Date
  • ANY 11-13-2025
  • SABS 11-05-2025
  • Dividend Yield
  • ANY N/A
  • SABS N/A
  • EPS Growth
  • ANY N/A
  • SABS N/A
  • EPS
  • ANY N/A
  • SABS N/A
  • Revenue
  • ANY $10,831,000.00
  • SABS $114,698.00
  • Revenue This Year
  • ANY N/A
  • SABS N/A
  • Revenue Next Year
  • ANY $36.07
  • SABS N/A
  • P/E Ratio
  • ANY N/A
  • SABS N/A
  • Revenue Growth
  • ANY N/A
  • SABS N/A
  • 52 Week Low
  • ANY $0.36
  • SABS $1.00
  • 52 Week High
  • ANY $1.90
  • SABS $6.60
  • Technical
  • Relative Strength Index (RSI)
  • ANY 61.14
  • SABS 72.43
  • Support Level
  • ANY $0.66
  • SABS $2.05
  • Resistance Level
  • ANY $0.73
  • SABS $2.18
  • Average True Range (ATR)
  • ANY 0.05
  • SABS 0.15
  • MACD
  • ANY 0.01
  • SABS 0.06
  • Stochastic Oscillator
  • ANY 70.84
  • SABS 95.54

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: